Literature DB >> 8663421

Secretogranin III is a sulfated protein undergoing proteolytic processing in the regulated secretory pathway.

J C Holthuis1, E J Jansen, G J Martens.   

Abstract

Secretogranin III (SgIII) is an acidic protein of unknown function that is present in the storage vesicles of many neuroendocrine cells. It is coexpressed with the prohormone proopiomelanocortin in the intermediate pituitary of Xenopus laevis. We developed an antiserum to investigate the biosynthesis of SgIII in pulse-chase incubated Xenopus neurointermediate lobes. SgIII was synthesized as a 61- or 63-kDa (N-glycosylated) protein and processed to a 48-kDa form which, in turn, was partially cleaved to fragments of 28 and 20 kDa. The 48-, 28-, and 20-kDa cleavage products, but not their precursors, were secreted. This secretion is regulated and can be blocked in parallel with that of proopiomelanocortin-derived peptides by the hypothalamic factors dopamine, gamma-aminobutyric acid, and neuropeptide Y. Coexpression of Xenopus SgIII with prohormone convertase (PC)1 or PC2 in transfected fibroblasts was sufficient to reconstitute the processing events observed in the neurointermediate lobes. Site-directed mutagenesis revealed that Xenopus SgIII is cleaved at two dibasic sites, namely Lys68-Arg69 and Arg237-Arg238. Pulse-chase incubations of lobes with Na2[35S]SO4 showed that SgIII is sulfated in the trans-Golgi network before it is processed. Finally, SgIII processing was found in several neuroendocrine cell types from various species. We conclude that SgIII is a precursor protein and that the intact molecule can only have an intracellular function, whereas an extracellular role can only be attributed to its cleavage products.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663421     DOI: 10.1074/jbc.271.30.17755

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Localization of p24 putative cargo receptors in the early secretory pathway depends on the biosynthetic activity of the cell.

Authors:  R P Kuiper; G Bouw; K P Janssen; J Rötter; F van Herp; G J Martens
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  Expression of Secretogranin III in Chicken Endocrine Cells: Its Relevance to the Secretory Granule Properties of Peptide Prohormone Processing and Bioactive Amine Content.

Authors:  Hiroshi Gomi; Satomi Morikawa; Naoki Shinmura; Hiroaki Moki; Tadashi Yasui; Azuma Tsukise; Seiji Torii; Tsuyoshi Watanabe; Yoshinori Maeda; Masahiro Hosaka
Journal:  J Histochem Cytochem       Date:  2015-02-11       Impact factor: 2.479

4.  Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model.

Authors:  J Jongsma; M H Oomen; M A Noordzij; W M Van Weerden; G J Martens; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

5.  Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas.

Authors:  Hiroshi Gomi; Takahiro Nagumo; Kazushi Asano; Makoto Konosu; Tadashi Yasui; Seiji Torii; Masahiro Hosaka
Journal:  J Histochem Cytochem       Date:  2022-04-09       Impact factor: 4.137

Review 6.  Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Authors:  Wei Li; Keith A Webster; Michelle E LeBlanc; Hong Tian
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

7.  Identification of differentially expressed genes in the zebrafish hypothalamic-pituitary axis.

Authors:  Sabrina Toro; Jeremy Wegner; Marc Muller; Monte Westerfield; Zoltan M Varga
Journal:  Gene Expr Patterns       Date:  2009-01-08       Impact factor: 1.224

8.  Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.

Authors:  Michelle E LeBlanc; Weiwen Wang; Xiuping Chen; Nora B Caberoy; Feiye Guo; Chen Shen; Yanli Ji; Hong Tian; Hui Wang; Rui Chen; Wei Li
Journal:  J Exp Med       Date:  2017-03-22       Impact factor: 14.307

9.  The pituitary gland of the European eel reveals massive expression of genes involved in the melanocortin system.

Authors:  Eirill Ager-Wick; Ron P Dirks; Erik Burgerhout; Rasoul Nourizadeh-Lillabadi; Daniëlle L de Wijze; Herman P Spaink; Guido E E J M van den Thillart; Katsumi Tsukamoto; Sylvie Dufour; Finn-Arne Weltzien; Christiaan V Henkel
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.